Home

Medtronic (MDT)

89.61
+0.08 (0.09%)
NYSE · Last Trade: Jul 18th, 5:34 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close89.53
Open89.98
Bid89.61
Ask90.55
Day's Range89.31 - 90.52
52 Week Range77.94 - 96.25
Volume6,413,150
Market Cap120.43B
PE Ratio (TTM)24.75
EPS (TTM)3.6
Dividend & Yield2.800 (3.12%)
1 Month Average Volume8,256,032

Chart

About Medtronic (MDT)

Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients. The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world. Read More

News & Press Releases

Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Diesinvestors.com
The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans.
Via Investor's Business Daily · July 18, 2025
Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Missesinvestors.com
The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.
Via Investor's Business Daily · July 17, 2025
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Missinvestors.com
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via Investor's Business Daily · July 17, 2025
MEDTRONIC PLC (NYSE:MDT) – A Potential Undervalued Opportunity in Healthcarechartmill.com
MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.
Via Chartmill · July 17, 2025
Sarepta To Lay Off 500 Employees After Two Patient Deaths; Shares Catapultinvestors.com
The company is also restructuring with the hopes of saving $400 million in expenses.
Via Investor's Business Daily · July 16, 2025
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analystsstocktwits.com
Via Stocktwits · July 11, 2025
Not Just a Patch Earns FDA, EU Clearance for CGM Patches Line, Expanding Diabetes Support Offerings
Australia, July 16, 2025 -- Not Just a Patch, a developer of medical CGM covers and patches solutions, has received U.S. Food and Drug Administration (FDA) clearance and European Class 1 medical device certification for its line of waterproof adhesive patches designed for continuous glucose monitoring (CGM) devices. These regulatory milestones will allow the company to expand its distribution footprint across North America and Europe, reinforcing market confidence in its CGM support products.
Analyst Expectations For Medtronic's Futurebenzinga.com
Via Benzinga · July 16, 2025
Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · July 16, 2025
MEDTRONIC PLC (NYSE:MDT) – A Reliable Dividend Stock Worth Consideringchartmill.com
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and decent financial health.
Via Chartmill · July 15, 2025
5 Robotics Stocks to Buy for the Future of Automationmarketbeat.com
Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.
Via MarketBeat · July 14, 2025
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fastbenzinga.com
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list.
Via Benzinga · July 12, 2025
Medtronic Stock Is Climbing Friday: What's Going On?benzinga.com
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.
Via Benzinga · July 11, 2025
The Best High Yield Medical Device Stock to Invest $1,000 in Right Nowfool.com
Via The Motley Fool · July 11, 2025
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Billfool.com
A steady dose of quality companies will keep your portfolio growing big and strong.
Via The Motley Fool · July 11, 2025
1 No-Brainer Dividend Stock to Buy Now and Hold Foreverfool.com
Via The Motley Fool · July 9, 2025
Medtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-Offstocktwits.com
Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives.
Via Stocktwits · July 8, 2025
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlookbenzinga.com
Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.
Via Benzinga · July 8, 2025
Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exitstocktwits.com
The company expects second-quarter revenue to grow by as much as 14% year-over-year, with foreign exchange headwinds expected to trim approximately $2.3 million from the top line.
Via Stocktwits · July 7, 2025
Bond Introduces World’s First Perpetual Smart Ring with Patent-Pending LifeDrive System
DETROIT, MI - July 7, 2025 - Bond, a Detroit-based consumer wearable technology company, today announced the official launch of the Bond Ring™, positioning itself as the most advanced wearable wellness device in the smart ring market. The groundbreaking technologies integrates 11 breakthrough capabilities while being powered by the company's patent-pending LifeDrive technology, marking a significant advancement in wearable health monitoring.
Via Get News · July 7, 2025
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skidsdexcom
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.
Via Investor's Business Daily · July 1, 2025
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheetsmarketbeat.com
These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors
Via MarketBeat · July 1, 2025
This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Mondaybenzinga.com
Via Benzinga · June 30, 2025
Beyond The Numbers: 6 Analysts Discuss Medtronic Stockbenzinga.com
Via Benzinga · June 30, 2025
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Foreverfool.com
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.
Via The Motley Fool · June 26, 2025